Exercise Training and Blood Flow in Adults with Type 2 Diabetes and Obesity
Tests whether exercise training improves blood flow to heart and muscle in adults with diabetes.
Key facts
- Who runs it
- University of Colorado, Denver
- Where
- Aurora and Charlottesville, United StatesSee the 2 sites
- Trial code
- Registry title
- Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 17 Jun 2022
- Expected to end
- 15 Feb 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Cardiovascular exercise
- Record updated
- 23 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 30 to 55 who do little physical activity and are overweight or obese. Some have type 2 diabetes and some do not.
- Age
- 30 to 55 years
- Sex
- Men and women
- Disease stage
- Type 2 diabetes, or no diabetes. Control HbA1c must not be above 5.7, and type 2 diabetes HbA1c must not be above 9.
- Earlier treatment
- People taking beta blockers, calcium channel blockers, insulin or Thiazolidinediones (TZD) cannot join.
Main reasons for not taking part
- Known cardiovascular disease
- Uncontrolled high blood pressure (SBP above 150 or DBP above 110)
- Smoking or tobacco use now or within the last 1 years
- Pregnant, nursing, or on hormonal therapy other than contraceptives
- Type 1 diabetes, or liver or kidney disease
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Sedentary (defined as less than 1 hour per week of physical activity)
- BMI: 25-40
- Men and women with and without type 2 diabetes
Who cannot take part
- Pregnant, nursing or hormonal therapy (other than contraceptives)
- Documented cardiovascular disease
- Uncontrolled hypertension: disease systolic blood pressure (SBP) > 150, diastolic blood pressure (DBP)> 110
- Obstructive pulmonary disease or asthma
- Physical impairment that would limit exercise ability
- Type 1 diabetes
- Hepatic or renal disease
- Subjects taking beta blockers, calcium channel blockers, insulin, or Thiazolidinediones (TZD)
- Control HbA1c > 5.7, T2DM HbA1c > 9
- Peripheral neuropathy
- Current or past smoking within the last 1 years
- Current tobacco use
- Anemia
- Peri or post-menopausal women
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 55 years old?
Where in United States
- University of ColoradoAurora, United StatesContact: Benjamin Juckett, MSTaking people
- University of VirginiaCharlottesville, United StatesContact: Lee Hartline, MEdTaking people
About the trial
What the trial wants to find out
The goal of this two-site grant proposal is to determine the role of the decreased insulin-mediated muscle perfusion found in type 2 diabetes in contributing to the development of cardiac and skeletal muscle dysfunction and subsequent functional exercise impairment. In addition, it is also our goal to determine whether exercise training attenuates insulin resistance and restores insulin-mediated perfusion to the heart and to skeletal muscle, leading to improved cardiac function and exercise performance.
The 2 groups in the trial
- Type 2 DiabetesTreatment being tested
Participants aged 30-55 with type 2 diabetes
Treatment: Cardiovascular exercise
- Healthy overweight controlTreatment being tested
Participants aged 30-55 with BMI 25-40 without type 2 diabetes
Treatment: Cardiovascular exercise
Results explained
A paper that names this trial, explained in plain words.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
- Plain-language title
- Exercise Training and Blood Flow in Adults with Type 2 Diabetes and ObesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04791371, who can take part
- Publications
- Record updated
- 23 March 2026